MMED vs PLSE: stock comparison and AI forecast
Minimed Group, Inc. (MMED) and Pulse Biosciences, Inc. (PLSE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MMED Minimed Group, Inc.
- Price
- $16.71 +42.5% · 6M
- Market Cap
- $4.70B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
PLSE Pulse Biosciences, Inc.
- Price
- $53.29 +172.0% · 6M
- Market Cap
- $3.80B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- MMED is 1.2 times larger than PLSE by market capitalization ($4.70B against $3.80B).
- Over the last six months PLSE returned +172.0% and MMED +42.5%.
- MMED carries 0.30 times debt per unit of equity, against 0.10 times for PLSE.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MMED | PLSE |
|---|---|---|
| Market Cap | $4.70B | $3.80B |
| P/B Ratio | 1.30x | 20.70x |
| Book Value/Share | $12.87 | $2.57 |
| Revenue/Share | – | $0.02 |
| FCF/Share | – | $-0.89 |
Profitability & Margins
| Metric | MMED | PLSE |
|---|---|---|
| ROE | – | -45.6% |
| ROA | – | -41.5% |
| ROIC | – | -46.2% |
| Gross Margin | – | 26.8% |
| Operating Margin | – | -5821.1% |
| Net Margin | – | -5603.9% |
| EBT Margin | – | 4043.9% |
| Tax Rate | – | 0.0% |
Financial Health
| Metric | MMED | PLSE |
|---|---|---|
| Current Ratio | 1.81x | 14.35x |
| Quick Ratio | 1.36x | 14.33x |
| D/E Ratio | 0.30x | 0.10x |
| Financial Leverage | 1.30x | 1.10x |
| Interest Coverage | – | -8308.5x |
| Working Capital | $635M | $179M |
Cash Flow
| Metric | MMED | PLSE |
|---|---|---|
| Operating Cash Flow | – | -$63M |
| Free Cash Flow | – | -$64M |
| Capital Spending | – | -$370K |
| FCF/Sales | – | -4263.9% |
| CapEx/Sales | – | 24.8% |
Operational Efficiency
| Metric | MMED | PLSE |
|---|---|---|
| Asset Turnover | – | 0.01x |
| Receivables Turnover | – | 5.0x |
| Inventory Turnover | – | 4.7x |
| Fixed Assets Turnover | – | 1.4x |
| Days Sales Outstanding | – | 73 days |
| Days Inventory | – | 77 days |
| Payables Period | – | 1007 days |
| Cash Conversion Cycle | – | -857 days |
Income Statement
| Metric | MMED | PLSE |
|---|---|---|
| Total Revenue | – | $1M |
| Operating Income | – | -$87M |
| Net Income | – | -$84M |
| R&D Expense | – | $57M |
| SG&A Expense | – | $46M |
| Cost of Goods Sold | – | $1M |
Dividend & Shareholder Information
| Metric | MMED | PLSE |
|---|---|---|
| Shares Outstanding | 281M | 71M |
MMED vs PLSE: stock comparison and AI forecast
Which is bigger, MMED or PLSE?
MMED is 1.2 times larger than PLSE by market capitalization ($4.70B against $3.80B).
Which stock performed better over the last six months, MMED or PLSE?
Over the last six months PLSE returned +172.0% and MMED +42.5%.
Which one does Intratio's AI model rank higher, MMED or PLSE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.